Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
DBV Technologies S.A., a pioneering biopharmaceutical company headquartered in France, focuses on developing innovative treatments for food allergies and other immune-mediated diseases. Founded in 2002, the company has made significant strides in the field of immunotherapy, particularly with its proprietary ViaskinĀ® technology, which offers a unique, non-invasive method for delivering therapeutic proteins through the skin.
With a strong presence in Europe and North America, DBV Technologies is recognised for its commitment to advancing patient care through its core product offerings, including the Viaskin Peanut patch, designed to desensitise individuals with peanut allergies. The company has achieved notable milestones, including successful clinical trials and partnerships that enhance its market position in the biopharmaceutical industry. As a leader in allergy treatment innovation, DBV Technologies continues to shape the future of immunotherapy.
-16 vs industry average
DBV Technologies S.A.ās score of 26 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for DBV Technologies S.A. yet.
DBV Technologies S.A., headquartered in France, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or commitments to the Science Based Targets initiative (SBTi) or other climate pledges.
As there is no available data on their carbon footprint or reduction initiatives, it is unclear how DBV Technologies S.A. is addressing climate change within its operations. The lack of emissions reporting may suggest an opportunity for the company to enhance its sustainability practices and align with industry standards for climate accountability.
In the context of the broader industry, many organisations are increasingly committing to transparent emissions reporting and setting ambitious reduction targets to mitigate climate impact. DBV Technologies S.A. may benefit from adopting similar strategies to demonstrate its commitment to environmental sustainability.
No climate goals have been disclosed for DBV Technologies S.A. yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Youāre welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more